Tag Archives: GILD

Hot Undervalued Stocks To Own For 2018

Ascena (NASDAQ:ASNA) is a retailer of apparel clothing for women and teen girls with numerous brands. Its operating segments are Premium, Value, Plus and Kids fashion, and some of its brand names are Maurices, Lane Bryant, Ann Taylor and LOFT. Together it owns around 8 brand names.

Ascena is a mid-cap company, part of S&P 400, with current market capitalisation of $988 million and share....More>>>

Sangamo Therapeutics Stock History

If you’ve been following the news lately, you might have heard about gene editing, a process that involves rewriting a person’s DNA to correct genetic disorders, and you’re wondering what all the buzz is about.

While gene editing is getting a lot of attention recently, it’s far from a new idea. Sangamo Therapeutics (NASDAQ:SGMO) has been working on gene-editing research....More>>>

3 High-Yield Stocks With Virtual Monopolies

Not many companies have monopolies, though some get pretty close. That list includes Russian telecom giantMobile TeleSystems (NYSE:MBT), biotech playerGilead Sciences, Inc.(NASDAQ:GILD), and tobacco makerAltria Group, Inc. (NYSE:MO). Each one has a slightly different virtual monopoly and they clearly have vastly different businesses. But if you are looking for income from seriously entrenched industry....More>>>

Sangamo Therapeutics Stock History

If you’ve been following the news lately, you might have heard about gene editing, a process that involves rewriting a person’s DNA to correct genetic disorders, and you’re wondering what all the buzz is about.

While gene editing is getting a lot of attention recently, it’s far from a new idea. Sangamo Therapeutics (NASDAQ:SGMO) has been working on gene-editing research....More>>>

Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions

Analysis focus: BHVN

Biohaven Pharmaceuticals (NYSE:BHVN) is a CNS-focused company with a strong pipeline with multiple drug candidates in late stage trials. The company recently announced a number of updates for its pipeline. For its lead candidate, rimegepant from the CGRP receptor antagonist platform, the company will report initial results from a long-term safety study in Q4 2018. In....More>>>

Top 5 Casino Stocks To Buy Right Now

You can bet on it: Sports gambling is about to expand, big time, in the United States.

Right now, the only place you can legally bet on sports is Nevada.

But on Monday, the Supreme Court struck down a federal law that prohibited legalized sports gambling anywhere but Nevada.

So what does this court decision mean, exactly?

Now that there is no longer a federal....More>>>

Top 5 Undervalued Stocks To Own For 2018

Shares of Gilead Sciences (GILD) have risen by over 10% since my initial article in April which called the stock a core buy in biotech with several value drivers.

GILD data by YCharts

Long time readers know that I麓m a fan of value catalyst plays, as being undervalued by itself is not a reason for me to be interested in a stock. Too often, selections we deem 篓cheap篓 or a 篓buy....More>>>

Week In Review: $3.4 Billion Week For China Life Science Deals

Armo BioSciences (NASDAQ:ARMO), a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly (NYSE:LLY) in a $1.6 billion transaction. Last year, Armo raised $67 million in a 2017 Series C-1 funding from China investors. Four months ago, Armo completed a $128 million IPO at a $500 million valuation. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and....More>>>

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big potential upside and big potential downside.

As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies.....More>>>

Top Clean Energy Stocks To Invest In 2018

Stocks opened slightly higher on Wednesday as investors begin to reap some rewards from the start of first quarter earnings season. Despite this recent market momentum, uncertainty is still present, which means investors need to continue to utilize Q1 earnings season in order to look for stocks set to top earnings estimates.

First quarter earnings season has already helped some stocks kick....More>>>